ULTRAGENYX PHARMACEUTICAL INC revenue breakdown overview

ULTRAGENYX PHARMACEUTICAL INC revenue for the last year amounted to 541.17 M EUR, the most of which — 265.47 M EUR — came from its highest performing source at the moment, Crysvita Royalty, the year earlier bringing 165.48 M EUR. The greatest contribution to the revenue figure was made by North America — last year it brought ULTRAGENYX PHARMACEUTICAL INC 328.88 M EUR, and the year before that — 278.28 M EUR.